AB Science S.A [AB] vs Vetoquinol S.A [VETO] Detailed Stock Comparison
AB Science S.A
Euronext
Loading...
Vetoquinol S.A
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: AB Science S.A wins in 7 metrics, Vetoquinol S.A wins in 9 metrics, with 0 ties. Vetoquinol S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | AB Science S.A | Vetoquinol S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -8.93 | 15.24 | AB Science S.A |
| Price-to-Book Ratio | N/A | 1.55 | N/A |
| Debt-to-Equity Ratio | -0.78 | 3.67 | AB Science S.A |
| PEG Ratio | -6.14 | 2.56 | AB Science S.A |
| EV/EBITDA | -16.29 | 7.16 | AB Science S.A |
| Profit Margin (TTM) | 116.42% | 10.88% | AB Science S.A |
| Operating Margin (TTM) | -488.48% | 16.28% | Vetoquinol S.A |
| EBITDA Margin (TTM) | N/A | 16.28% | N/A |
| Return on Equity | 32.97% | 10.64% | AB Science S.A |
| Return on Assets (TTM) | -15.62% | 6.66% | Vetoquinol S.A |
| Free Cash Flow (TTM) | $370,000 | $68.15M | Vetoquinol S.A |
| Dividend Yield | N/A | 1.27% | N/A |
| 1-Year Return | 39.58% | -20.94% | AB Science S.A |
| Price-to-Sales Ratio (TTM) | 78.81 | 1.66 | Vetoquinol S.A |
| Enterprise Value | $92.64M | $707.82M | Vetoquinol S.A |
| EV/Revenue Ratio | 86.42 | 1.31 | Vetoquinol S.A |
| Revenue per Share (TTM) | $0 | $46 | Vetoquinol S.A |
| Earnings per Share (Diluted) | $-0.15 | $4.98 | Vetoquinol S.A |
| Beta (Stock Volatility) | 1.59 | 0.75 | Vetoquinol S.A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
AB Science S.A vs Vetoquinol S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| AB Science S.A | 0.91% | -6.29% | -6.29% | -6.94% | -14.10% | 48.89% |
| Vetoquinol S.A | -1.06% | -1.46% | -0.80% | 1.92% | 3.19% | -2.11% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| AB Science S.A | 39.58% | -83.99% | -84.38% | -90.84% | -84.89% | -84.89% |
| Vetoquinol S.A | -20.94% | -39.41% | 2.20% | 100.54% | 227.75% | 227.75% |
Performance & Financial Health Analysis: AB Science S.A vs Vetoquinol S.A
| Metric | AB | VETO |
|---|---|---|
| Market Information | ||
| Market Cap | €84.48M | €895.57M |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 465,348 | 9,763 |
| 90 Day Avg. Volume | 377,316 | 5,032 |
| Last Close | €1.34 | €74.40 |
| 52 Week Range | €0.77 - €2.34 | €63.60 - €98.40 |
| % from 52W High | -42.91% | -24.39% |
| All-Time High | €23.00 (Oct 29, 2012) | €161.00 (Nov 01, 2021) |
| % from All-Time High | -94.17% | -53.79% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.01% |
| Quarterly Earnings Growth | N/A | 0.50% |
| Financial Health | ||
| Profit Margin (TTM) | 1.16% | 0.11% |
| Operating Margin (TTM) | -4.88% | 0.16% |
| Return on Equity (TTM) | 0.33% | 0.11% |
| Debt to Equity (MRQ) | -0.78 | 3.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-0.37 | €48.82 |
| Cash per Share (MRQ) | €0.13 | €17.49 |
| Operating Cash Flow (TTM) | €525,000 | €85.83M |
| Levered Free Cash Flow (TTM) | €3.76M | €61.39M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.27% |
| Last 12-Month Dividend | N/A | €0.89 |
Valuation & Enterprise Metrics Analysis: AB Science S.A vs Vetoquinol S.A
| Metric | AB | VETO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -8.93 | 15.24 |
| Forward P/E | -6.14 | 14.19 |
| PEG Ratio | -6.14 | 2.56 |
| Price to Sales (TTM) | 78.81 | 1.66 |
| Price to Book (MRQ) | N/A | 1.55 |
| Market Capitalization | ||
| Market Capitalization | €84.48M | €895.57M |
| Enterprise Value | €92.64M | €707.82M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 86.42 | 1.31 |
| Enterprise to EBITDA | -16.29 | 7.16 |
| Risk & Other Metrics | ||
| Beta | 1.59 | 0.75 |
| Book Value per Share (MRQ) | €-0.37 | €48.82 |
Financial Statements Comparison: AB Science S.A vs Vetoquinol S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AB | VETO |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AB | VETO |
|---|---|---|
| Cash & Equivalents | €7.99M | €206.33M |
| Total Current Assets | €14.52M | €421.18M |
| Total Current Liabilities | €20.43M | €141.53M |
| Long-Term Debt | €14.55M | €11.22M |
| Total Shareholders Equity | €-23.75M | €575.93M |
| Retained Earnings | N/A | €58.69M |
| Property, Plant & Equipment | €256,000 | €17.79M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AB | VETO |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AB | VETO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 465,348 | 9,763 |
| Average Daily Volume (90 Day) | 377,316 | 5,032 |
| Shares Outstanding | 64.64M | 11.80M |
| Float Shares | 23.98M | 3.83M |
| % Held by Insiders | 0.33% | 0.67% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: AB Science S.A vs Vetoquinol S.A
| Metric | AB | VETO |
|---|---|---|
| Last 12-Month Dividend | N/A | €0.89 |
| Last 12-Month Dividend Yield | N/A | 1.27% |
| 3-Year Avg Annual Dividend | N/A | €0.85 |
| 3-Year Avg Dividend Yield | N/A | 0.99% |
| 3-Year Total Dividends | N/A | €2.54 |
| Ex-Dividend Date | N/A | Jun 04, 2025 |